Suppr超能文献

相似文献

1
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.
Cell. 2021 Jul 22;184(15):3998-4015.e19. doi: 10.1016/j.cell.2021.05.027. Epub 2021 Jun 21.
2
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):E2116-25. doi: 10.1073/pnas.1307185110. Epub 2013 May 20.
3
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Proc Natl Acad Sci U S A. 2021 Jul 27;118(30). doi: 10.1073/pnas.2023739118.
5
TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
J Immunol. 2017 Feb 15;198(4):1503-1511. doi: 10.4049/jimmunol.1601670. Epub 2017 Jan 4.
8
Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10113-8. doi: 10.1073/pnas.0711106105. Epub 2008 Jul 17.
9
Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
Blood. 2012 Nov 29;120(23):4560-70. doi: 10.1182/blood-2012-04-421420. Epub 2012 Oct 9.

引用本文的文献

2
Regulatory T cells in cancer anti-PD-(L)1 therapy.
Hum Cell. 2025 Aug 25;38(5):150. doi: 10.1007/s13577-025-01280-1.
3
Endothelial activation and stress index for prediction of mortality in asthma.
Front Med (Lausanne). 2025 Jul 9;12:1622944. doi: 10.3389/fmed.2025.1622944. eCollection 2025.
6
FAM111B Overexpression and Immune Cell Infiltration: Implications for Ovarian Cancer Immunotherapy.
Biomedicines. 2025 May 24;13(6):1295. doi: 10.3390/biomedicines13061295.
8
Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets.
MedComm (2020). 2025 Jun 16;6(7):e70262. doi: 10.1002/mco2.70262. eCollection 2025 Jul.
9
Regulatory T cells in the tumour microenvironment.
Nat Rev Cancer. 2025 Jun 10. doi: 10.1038/s41568-025-00832-9.
10
Arginine methylation patterns in LUAD: defining prognostic subtypes and relevance to immunotherapy.
Discov Oncol. 2025 May 21;16(1):853. doi: 10.1007/s12672-025-02549-5.

本文引用的文献

1
Regulatory T Cells and Human Disease.
Annu Rev Immunol. 2020 Apr 26;38:541-566. doi: 10.1146/annurev-immunol-042718-041717. Epub 2020 Feb 4.
3
Targeting the CBM complex causes T cells to prime tumours for immune checkpoint therapy.
Nature. 2019 Jun;570(7759):112-116. doi: 10.1038/s41586-019-1215-2. Epub 2019 May 15.
4
PD-1 regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008. doi: 10.1073/pnas.1822001116. Epub 2019 Apr 26.
5
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4 T Cell Immunity.
Cell. 2019 Apr 18;177(3):556-571.e16. doi: 10.1016/j.cell.2019.02.005. Epub 2019 Apr 4.
6
Human FOXP3 Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer.
Immunity. 2019 Feb 19;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020.
8
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):609-618. doi: 10.1073/pnas.1812186116. Epub 2018 Dec 26.
9
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3 Regulatory T Cells (Tregs) in Human Cancers-Letter.
Clin Cancer Res. 2019 Jun 1;25(11):3468. doi: 10.1158/1078-0432.CCR-18-3740. Epub 2018 Dec 4.
10
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.
Cell. 2018 Oct 4;175(2):313-326. doi: 10.1016/j.cell.2018.09.035.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验